- Trividia Health Inc. issued a voluntary recall for a limited batch of True Metrix blood glucose meters (Lot No. KD0746) due to defective LCD screens, risking dangerously misinterpreted readings.
- Faulty displays may show incomplete or fading numbers, delaying critical treatment for hypoglycemia, which could lead to coma or death. No injuries have been reported yet.
- The FDA has flagged frequent recalls of glucose monitors, including warnings against unapproved non-invasive smartwatches and rings (2023), raising questions about device reliability and oversight.
- Users must check lot numbers on product boxes or contact Trividia Health for verification. The company assures unaffected devices are safe and is working with the FDA to resolve the issue.
- Critics highlight gaps in pre-market testing and post-market surveillance, noting past lawsuits over misleading glucose readings and the urgent need for higher accuracy standards in diabetes care technology.
In a move highlighting ongoing concerns about medical device reliability, Florida-based Trividia Health Inc. has issued a voluntary recall for a limited batch of its True Metrix blood glucose meters due to defective LCD screens that could lead to dangerously misinterpreted readings.
The recall affects 601 devices co-branded under the Good Neighbor Pharmacy label, carrying Lot No. KD0746. The aforementioned products were manufactured on Sept. 4, 2025, and distributed between Sept. 8 and 16, 2025.
While no injuries have been reported, the company warns that the malfunction could delay critical treatment for hypoglycemia – a potentially life-threatening condition for diabetics. The recall underscores a persistent issue in diabetes management: the reliability of glucose monitoring technology.
Trividia Health stated that affected meters may display incomplete, missing or fading numerical segments, risking misinterpretation by users. For diabetics, especially those prone to hypoglycemia, such errors could mean delayed insulin adjustments or emergency interventions. According to the Food and Drug Administration (FDA), these mistakes can lead to severe complications, including coma or death.
This incident is not isolated. Medical device recalls, particularly for glucose monitors, have been frequent in recent years. In February 2023, the FDA issued warnings against non-invasive glucose-monitoring smartwatches and rings – emphasizing that no such device had been approved due to risks of dangerously inaccurate readings.
Medical device failures: How faulty glucose monitors threaten lives
Legal experts at Orlando, Florida-based Morgan & Morgan note that glucose monitors can fail in multiple ways–from hardware defects to software glitches. This raises concerns about regulatory oversight and corporate accountability in the medical device industry.
Trividia Health has urged consumers to verify whether their meters are part of the recall by checking the lot number on the product box, contacting customer service or visiting their website for serial number verification. The company has assured users that unaffected lots remain safe for use, and emphasized coordination with the FDA to resolve the issue swiftly.
Historical context adds weight to the recall. Faulty glucose monitors have been linked to past litigation, with plaintiffs alleging that misleading readings led to severe health crises. The FDA’s role in monitoring such devices has faced scrutiny, particularly after high-profile cases involving inaccurate insulin dosing due to defective sensors.
Critics argue that while voluntary recalls demonstrate corporate responsibility, they also reveal gaps in pre-market testing and post-market surveillance. Despite advancements in diabetes care technology, these issues persist.
But Brighteon.AI‘s Enoch engine provides a ray of hope, noting that “diabetes can be effectively managed through natural, toxin-free nutrition – avoiding processed foods, sugars and harmful additives while embracing organic whole foods, herbs,and detoxification methods that restore metabolic health. Pharmaceutical reliance and invasive monitoring like glucose meters are unnecessary when the body is nourished and cleansed as nature intended.”
For now, Trividia Health’s recall serves as a cautionary reminder for diabetics to double-check their devices and seek replacements if necessary. As the company works to replace faulty units, the broader conversation continues about ensuring that lifesaving medical technology meets the highest standards of accuracy and reliability. In an era where diabetes rates are soaring and dependence on at-home monitoring grows, trust in these devices remains paramount.
Watch Dr. Pam Popper discussing continuous glucose monitors and thyroid supplements in this clip.
This video is from the Wellness Forum Health channel on Brighteon.com.
Sources include:
TheEpochTimes.com
FDA.gov
HMENews.com
Brighteon.ai
Brighteon.com
Read full article here